Paul H Weinreb

Title: Paul H. Weinreb: Innovator in Antigen Binding Proteins

Introduction

Paul H. Weinreb is a notable inventor based in Weston, MA (US), recognized for his contributions to the field of biotechnology. He holds a total of five patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

One of his latest patents focuses on Oncostatin M receptor antigen binding proteins. This invention provides anti-oncostatin M receptor-β (OSMR) antigen binding proteins, including antibodies and functional fragments, derivatives, muteins, and variants thereof. These OSMR antigen binding proteins are designed to interfere with the binding of Oncostatin M (OSM) and/or Interleukin-31 (IL-31) to OSMR. In various embodiments, these anti-OSMR antigen binding proteins serve as valuable tools for studying diseases and disorders associated with OSMR. They are particularly useful in methods aimed at treating such diseases and disorders linked to the binding of OSM and/or IL-31 to OSMR.

Career Highlights

Paul H. Weinreb is currently associated with Kiniksa Pharmaceuticals, Ltd., where he continues to contribute to groundbreaking research and development in the pharmaceutical industry. His work has significantly impacted the understanding and treatment of various medical conditions.

Collaborations

Throughout his career, Paul has collaborated with esteemed colleagues, including Heather A. Arnett and Sabine Schadow Escobar. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Paul H. Weinreb stands out as a prominent inventor in the field of biotechnology, particularly in the development of antigen binding proteins. His innovative work continues to pave the way for advancements in medical treatments and research.